Home › Pharmacology › Drugs Acting on Adrenergic Synapses

Drugs Acting on Adrenergic Synapses

For medical students2 min readUpdated 2026-10-10

Drugs acting on adrenergic synapses are a broad class of pharmacological agents that affect neurotransmission mediated by norepinephrine and epinephrine. They can either enhance or inhibit adrenergic activity by targeting various stages of neurotransmitter turnover or by binding directly to adrenergic receptors.

Two Main GroupsAll drugs are divided into those that stimulate and those that block synaptic transmission.

Beta-1Receptors of the "heart and kidneys": their stimulation enhances myocardial contractility and renin secretion.

Beta-2Receptors of "relaxation": responsible for bronchodilation and reduction of vascular tone.

FeedbackPresynaptic alpha-2 receptors inhibit neurotransmitter release, whereas beta receptors stimulate it.

Mechanisms of Action on Synaptic Transmission

Pharmacological agents can interfere with synaptic function at several levels. The primary mechanisms include:

Stimulation of neurotransmitter release. This is the mechanism of action for sympathomimetics (e.g., ephedrine, amphetamine, and dietary tyramine). They displace norepinephrine molecules from presynaptic terminals directly into the synaptic cleft.
Direct receptor action. Agents act as adrenomimetics (direct agonists) or adrenoreceptor antagonists (blockers). These groups are the most widely used in clinical practice.
Inhibition of reuptake. Cocaine and tricyclic antidepressants (e.g., amitriptyline, imipramine) block transporter systems on the presynaptic membrane. Norepinephrine accumulates in the synaptic cleft, significantly amplifying its effects.
Inhibition of neurotransmitter degradation. MAO inhibitors (e.g., non-selective nialamide) block the monoamine oxidase enzyme in the cytoplasm, preventing the degradation of free norepinephrine.
Disruption of storage. Sympatholytics (e.g., reserpine) block vesicular monoamine transporters. Norepinephrine cannot enter the vesicles, leading to the depletion of neurotransmitter stores.

Types and Localization of Adrenergic Receptors

Receptors are divided into two main types — $\alpha$ (subtypes $\alpha_1$, $\alpha_2$) and $\beta$ (subtypes $\beta_1$, $\beta_2$, $\beta_3$). Their functions and sensitivity depend on their anatomical location relative to the synapse:

Postsynaptic (predominantly $\alpha_1$, $\beta_1$). Located on the membrane of target cells (effector cells). They are activated by norepinephrine released from nerve terminals during classical synaptic transmission.
Extrasynaptic (predominantly $\alpha_2$, $\beta_2$). Located on cells lacking direct sympathetic innervation. They respond to circulating epinephrine (adrenal medullary hormone), while $\alpha_2$ receptors also respond to circulating norepinephrine.
Presynaptic (predominantly $\alpha_2$). Located on the nerve terminals themselves, regulating synaptic transmission via a negative feedback loop: their stimulation inhibits further release of norepinephrine from varicosities.

Physiological Effects of Receptor Stimulation

Each receptor subtype triggers specific responses in target organs.

Effects of $\alpha$-adrenergic receptors:

$\alpha_1$-receptors: Mediate smooth muscle contraction in blood vessels (vasoconstriction) and contraction of the radial muscle of the iris (pupillary dilation — mydriasis). They are also located in the sphincters of the gastrointestinal tract, urinary bladder, and the splenic capsule.
$\alpha_2$-receptors: Constrict blood vessels and, at the presynaptic level, decrease norepinephrine release.

Effects of $\beta$-adrenergic receptors:

$\beta_1$-receptors: Stimulate the heart, increasing contractility (positive inotropic effect), heart rate (positive chronotropic effect), and conduction velocity (positive dromotropic effect). This sharply increases myocardial oxygen demand. In the kidneys, they activate renin secretion.
$\beta_2$-receptors: Mediate relaxation. They decrease vascular tone (vasodilation), dilate bronchi, and relax the uterine myometrium. Metabolically, they promote glycogenolysis.

Classification of Stimulating Agents

All drugs that stimulate adrenergic synapses can be divided into two subgroups based on their mechanism of action:

Adrenomimetics (direct-acting). Directly bind to and activate adrenergic receptors, mimicking the effects of norepinephrine. Depending on their selectivity, they are classified as $\alpha$-adrenomimetics, $\beta$-adrenomimetics, and mixed $\alpha,\beta$-adrenomimetics.
Sympathomimetics (indirect-acting). Do not interact directly with receptors. Their function is to increase the release or accumulation of the endogenous neurotransmitter in the synaptic cleft. The accumulated norepinephrine then secondary activates the receptors.

Mnemonic

To remember the localization of $\beta$-receptors, use the "organ rule": $\beta_1$ — you have 1 heart (stimulation of myocardial function), $\beta_2$ — you have 2 lungs (bronchodilation).

Frequently asked questions

What is the classification of adrenergic antagonists (blockers)?

The classification of adrenergic blockers is based on their preferential affinity for specific receptor types. There are three main groups of drugs:

$\alpha$-blockers — block alpha receptors. According to their selectivity, they are divided into non-selective ($\alpha_1, \alpha_2$) and selective ($\alpha_1$).
$\beta$-blockers — block beta receptors. They are subdivided into non-selective (blocking both $\beta_1$ and $\beta_2$) and selective $\beta_1$-blockers.
$\alpha, \beta$-blockers — mixed-action drugs that block both types of receptors.

Which drugs belong to $\beta_2$-adrenomimetics?

The $\beta_2$-adrenomimetic group includes drugs categorized by duration of action into short-acting and long-acting agents. Key representatives include:

Fenoterol — a short-acting drug used to relieve acute bronchospasm.
Salbutamol — a short-acting "rescue" medication for acute bronchospasm.
Formoterol — a long-acting drug used for maintenance therapy.
Hexoprenaline — a selective agent used primarily in obstetrics.

What are the indications for $\alpha$-adrenomimetics?

Indications and clinical applications of $\alpha$-adrenomimetics can be illustrated using phenylephrine (mesaton):

In cardiovascular collapse — administration may be used for its vasopressor effect.
Topical ophthalmic drops — induces pupillary dilation (mydriasis) via contraction of the radial muscle of the iris.

Pharmacodynamic basis of these effects: stimulation of postsynaptic vascular $\alpha_1$-adrenoreceptors causes vasoconstriction and elevates blood pressure.

Which enzymes degrade norepinephrine?

The degradation and inactivation of norepinephrine in the synapse are carried out by two main enzymes:

Monoamine oxidase (MAO, including mitochondrial MAO-A) — responsible for the enzymatic breakdown of free neurotransmitter inside presynaptic nerve terminals (in the cytoplasm).
Catechol-O-methyltransferase (COMT) — participates in the enzymatic breakdown of the remaining neurotransmitter fraction.

These enzymes metabolize the portion of catecholamines that has not undergone neuronal reuptake.

What is the difference between adrenomimetics and sympathomimetics?

Adrenomimetics act directly on adrenergic receptors, substituting for the natural neurotransmitter. Sympathomimetics do not touch the receptors, but instead cause the neuron to accumulate or release more of its own norepinephrine.

How do receptors regulate the release of norepinephrine?

The process is controlled by presynaptic receptors. Activation of alpha-2 receptors inhibits neurotransmitter release (negative feedback), whereas stimulation of beta receptors increases it (positive feedback).

Why does diastolic blood pressure decrease upon beta-receptor stimulation?

Stimulation of $\beta_2$-receptors in the smooth muscle of blood vessels leads to their relaxation. This reduces total peripheral vascular resistance, resulting in a drop in diastolic pressure.

Go deeper

Mechanisms of action of sympatholytics and depletion of neurotransmitter stores
Pharmacodynamics of adrenergic blockers and their application in cardiology
Hemodynamic effects: changes in systolic and mean arterial pressure during synapse stimulation
Mechanisms of neuronal reuptake and the impact of antidepressants
Localization and functions of $\beta_3$-adrenergic receptors